Conduent Launches GenAI Solution to Transform FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions provider, has introduced a new GenAI-powered platform aimed at automating the detection of reportable events. This innovation targets Pharma and Life Sciences companies, enhancing their compliance with FDA regulations.
Technology and Impact
Powered by Microsoft Azure OpenAI, the solution automates the identification of reportable events across all customer channels, setting a new industry standard for FDA compliance.
Contact Information
- Media: Sean Collins, Conduent, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent, [email protected]
"Conduent Applies GenAI to Revolutionize Detection of Reportable Events and Sets New Standard for FDA Compliance."
Conduent's innovative AI solution streamlines regulatory processes, offering Pharma and Life Sciences firms a powerful tool to ensure timely and accurate event reporting.
Would you like the summary to emphasize technological innovation or compliance benefits more?